Lucid Diagnostics (LUCD) Shares Issued (2022 - 2025)
Historic Shares Issued for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $27.0 million.
- Lucid Diagnostics' Shares Issued changed N/A to $27.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.2 million, marking a year-over-year increase of 107917500.0%. This contributed to the annual value of $4000.0 for FY2024, which is 9977.78% down from last year.
- Per Lucid Diagnostics' latest filing, its Shares Issued stood at $27.0 million for Q3 2025.
- In the past 5 years, Lucid Diagnostics' Shares Issued registered a high of $27.0 million during Q3 2025, and its lowest value of -$1.1 million during Q2 2022.
- Over the past 4 years, Lucid Diagnostics' median Shares Issued value was $284000.0 (recorded in 2023), while the average stood at $5.0 million.
- Its Shares Issued has fluctuated over the past 5 years, first soared by 5187.17% in 2023, then plummeted by 9859.15% in 2024.
- Quarter analysis of 4 years shows Lucid Diagnostics' Shares Issued stood at $1.1 million in 2022, then soared by 35.48% to $1.5 million in 2023, then tumbled by 99.74% to $4000.0 in 2024, then skyrocketed by 674825.0% to $27.0 million in 2025.
- Its Shares Issued was $27.0 million in Q3 2025, compared to $16.2 million in Q2 2025 and $3000.0 in Q1 2025.